Changchun GeneScience Pharmaceutical Co., Ltd.
- Country
- 🇨🇳China
- Ownership
- -
- Established
- 1948-01-01
- Employees
- -
- Market Cap
- -
- Website
- http://english.ciac.cas.cn/
Clinical Study to Evaluate the Efficacy and Safety of GS1-144 Tablets in the Treatment of Moderate to Severe Vasomotor Symptoms in Chinese Postmenopausal Women.
- First Posted Date
- 2024-12-10
- Last Posted Date
- 2024-12-19
- Lead Sponsor
- Changchun GeneScience Pharmaceutical Co., Ltd.
- Target Recruit Count
- 129
- Registration Number
- NCT06726850
- Locations
- 🇨🇳
Peking Union Medical College Hospital, Beijing, Beijing, China
A Real-world Study of Long-acting Growth Hormone Injection for Turner Syndrome
- Conditions
- First Posted Date
- 2024-12-09
- Last Posted Date
- 2024-12-09
- Lead Sponsor
- Changchun GeneScience Pharmaceutical Co., Ltd.
- Target Recruit Count
- 743
- Registration Number
- NCT06722079
- Locations
- 🇨🇳
Tongji hospital affiliated to tongji medicalcollege of huazhong university of science＆technology, Wuhan, Hubei, China
A Study of GensSci098 in Subjects with Active Thyroid Eye Disease
- Conditions
- Interventions
- First Posted Date
- 2024-08-26
- Last Posted Date
- 2024-11-07
- Lead Sponsor
- Changchun GeneScience Pharmaceutical Co., Ltd.
- Target Recruit Count
- 76
- Registration Number
- NCT06569758
- Locations
- 🇨🇳
Shanghai Ninth People's hospital, Shanghai Jiaotong University School of Medication, Shanghai, Shanghai, China
To Evaluate Recombinant Human Follicle Stimulating Hormone-CTP Fusion Protein Injection or Placebo Combined With Chorionic Gonadotropin for Injection
- First Posted Date
- 2024-08-20
- Last Posted Date
- 2024-08-20
- Lead Sponsor
- Changchun GeneScience Pharmaceutical Co., Ltd.
- Target Recruit Count
- 60
- Registration Number
- NCT06561594
- Locations
- 🇨🇳
Anhui Children's Hospital, Hefei, Anhui, China
🇨🇳Beijing Children's Hospital, Capital Medical University, Beijing, Beijing, China
🇨🇳Henan Children's Hospital Zhengzhou Children's Hospital, Zhengzhou, Henan, China
A Bioequivalence Study of Two Different Dosage Form of Genakumab
- Conditions
- Interventions
- First Posted Date
- 2024-06-11
- Last Posted Date
- 2024-11-08
- Lead Sponsor
- Changchun GeneScience Pharmaceutical Co., Ltd.
- Target Recruit Count
- 178
- Registration Number
- NCT06451848
- Locations
- 🇨🇳
Chengdu Xinhua Hospital, Chengdu, Sichuan, China
Safety, Efficacy and Pharmacokinetic Behavior of Leuprolide Injectable Emulsion for Premenopausal Breast Cancer Subjects.
- Conditions
- Interventions
- First Posted Date
- 2024-06-07
- Last Posted Date
- 2024-06-07
- Lead Sponsor
- Changchun GeneScience Pharmaceutical Co., Ltd.
- Target Recruit Count
- 200
- Registration Number
- NCT06449027
- Locations
- 🇨🇳
Fudan University Shanghai Cancer Center, Shanghai, Shanghai, China
A Phase I Clinical Study Evaluating the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single and Multiple Oral Dose Escalation of GS1-144 Tablets and the Effects of Food on the Pharmacokinetics of GS1-144 in a Chinese Population
- Conditions
- Interventions
- First Posted Date
- 2024-04-25
- Last Posted Date
- 2024-04-25
- Lead Sponsor
- Changchun GeneScience Pharmaceutical Co., Ltd.
- Target Recruit Count
- 110
- Registration Number
- NCT06385158
- Locations
- 🇨🇳
Huashan Hospital, Fudan University, Shanghai, Shanghai, China
A Bioavailability Study of Two Different PEG-rhGH Preparations.
- Conditions
- Interventions
- First Posted Date
- 2024-04-25
- Last Posted Date
- 2024-04-25
- Lead Sponsor
- Changchun GeneScience Pharmaceutical Co., Ltd.
- Target Recruit Count
- 16
- Registration Number
- NCT06385145
- Locations
- 🇨🇳
Chengdu Xinhua Hospital, Chengdu, Sichuan, China
A Bioequivalence Study of Two Different PEG-rhGH Preparations.
- Conditions
- Interventions
- First Posted Date
- 2024-03-26
- Last Posted Date
- 2024-11-08
- Lead Sponsor
- Changchun GeneScience Pharmaceutical Co., Ltd.
- Target Recruit Count
- 87
- Registration Number
- NCT06331026
- Locations
- 🇨🇳
Chengdu Xinhua Hospital, Chengdu, Sichuan, China
Long-term Follow-up Safety of a Single Injection of GenSci094 for Ovarian Stimulation Using Daily Recombinant FSH as Reference
- Conditions
- First Posted Date
- 2024-03-20
- Last Posted Date
- 2024-03-20
- Lead Sponsor
- Changchun GeneScience Pharmaceutical Co., Ltd.
- Target Recruit Count
- 158
- Registration Number
- NCT06321107
- Locations
- 🇨🇳
The Sixth Affiliated Hospital, Sun Yat-sen University Guangdong Gastrointestinal Hospital, Guangzhou, Guangdong, China